Join | Relocating? | Member Directory |

Member News

The Leukemia & Lymphoma Society, OHSU launch “Beat AML” cancer research initiative

The Leukemia & Lymphoma Society and Oregon Health & Science University’s Knight Cancer Institute are launching a groundbreaking collaboration to improve outcomes for acute myeloid leukemia (AML). The “Beat AML” cancer research initiative takes a next-generation personalized medicine approach to vastly accelerate research findings and ultimately improve outcomes for patients with AML. The three-year project will be led by Dr. Brian Druker and researchers at Stanford University, UT Southwestern Medical Center and Huntsman Cancer Institute at the University of Utah. Additionally, Intel and Illumina are providing computational analysis and genetic sequencing expertise. More information >>